[1]
“Stratifying Cardiovascular–Kidney–Metabolic Syndrome by Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pathophysiology-Anchored, India-Contextualised Framework for Node-Directed Pharmacotherapy”, d, vol. 5, no. 1, pp. 1–23, Jul. 2026, Accessed: Jul. 28, 2026. [Online]. Available: https://thediabzen.com/index.php/d/article/view/40